B-Type Natriuretic Peptide-Guided Treatment for Predicting Outcome in Patients Hospitalized in Sub-Intensive Care Unit With Acute Heart Failure

Journal of Cardiac Failure

Volumn 14, Issue 3, 2008, Pages 219-224

  Valle, Roberto ^a   Aspromonte, Nadia ^b   Giovinazzo, Prospero ^a   Carbonieri, Emanuele ^a   Chiatto, Mario ^a   di Tano, Giuseppe ^c   Feola, Mauro ^d   Milli, Massimo ^e   Fontebasso, Alessandra ^a   Barro, Sabrina ^a   Bardellotto, Stefania ^a   Milani, Loredano ^a  

^a Ospedale Civile   (Italy)

^b SPIRITO SANTO HOSPITAL   (Italy)

^c Azienda Ospedaliera Papardo   (Italy)

^d S CROCE E CARLE HOSPITAL   (Italy)

^e SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

Author keywords

B type natriuretic peptide; discharge criteria; heart failure; hospitalization; prognosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; ENALAPRIL; FUROSEMIDE; VASODILATOR AGENT;

ACUTE HEART FAILURE; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYDRATION; IMPEDANCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; ITALY; MALE; MONITORING, PHYSIOLOGIC; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PATIENT DISCHARGE; PATIENT READMISSION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL RATE;

EID: 41249098666     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2007.10.009     Document Type: Article

References (26)

1. The Task Force on Acute Heart Failure of the European Society of Cardiology. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 26 (2005) 384-416
2. Haldeman G.A., Croft J.B., Giles W.H., et al. Hospitalization of patients with heart failure: national hospital discharge survey 1985-1995. Am Heart J 137 (1999) 352-360
3. Di Lenarda A., Scherillo M., Maggioni A.P., et al. Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds. The TEMISTOCLE study. Am Heart J 146 (2003) E12
4. McAlister F.A., Stewart S., Ferrua S., et al. Multidisciplinary strategies for the management of heart failure patients at high risk for admission. A systematic review of randomized trials. J Am Coll Cardiol 44 (2004) 810-819
5. Doust J.A., Pietrzak E., Dobson A.J., and Glasziou P.P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: a systematic review. BMJ 330 (2005) 625-634
6. Kazanegra R., Chen V., Garcia A., et al. A rapid test for B-type natriuretic peptide (BNP) correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 7 (2001) 21-29
7. Johnson W., Omland T., Hall C., et al. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol 39 (2002) 1623-1629
8. Cleland J.C.F., and Goode K. Natriuretic peptide for heart failure. Fashionable? Useful? Necessary?. Eur J Heart Fail 6 (2004) 253-255
9. McKee P.A., Castelli W.P., McNamara P.M., and Kannel W.B. The natural history of CHF. The Framingham study. N Engl J Med 285 (1971) 1442-1446
10. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
11. Valle R, Aspromonte N, Carbonieri E, et al. Fall in readmission rate for heart failure after implementation of B-type natriuretic peptide testing for discharge decision: a retrospective study. Internat J Cardiol 2007 Sep 3; [Epub ahead of print].
12. Howard P.A., and Dunn M.I. Aggressive diuresis for severe heart failure in the elderly. Chest 119 (2001) 807-810
13. Paterna S., Di Pasquale P., Parrinello G., et al. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure. J Am Coll Cardiol 45 (2005) 1997-2003
14. Silver M.A., Maisel A., Yancy C.W., McCollough P.A., Burnett J.C., Francis G.S., et al. BNP consensus panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Cong Heart Fail 10 Suppl 3 (2004) 1-27
15. Peacock W.F. Rapid optimization: strategies for optimal care of decompensated congestive heart failure patients in the emergency department. Rev Cardiovasc Med 3 Suppl 4 (2002) 41-48
16. Valle R., Aspromonte N., Feola M., et al. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function. J Card Fail 7 (2005) 498-503
17. Biosite. Triage BNP package insert (2002), Biosite Inc, San Diego, CA
18. Valle R., Bagolin E., Canali C., et al. The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients. Eur J Echocard 7 (2006) 40-44
19. Piccoli A. Analisi di bioimpedenza per la clinica. Pinelli Editore. Milano. 2003.
20. Fonarow G.C. ADHERE Scientific Advisory Committee. The Acute Decompensated Heart Failure National Registry (ADHERE): Opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 4 Suppl 7 (2003) S21-S30
21. Androne, Hryniewicz, Hudaihed, et al. Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol 93 (2004) 1254-1259
22. Kinnunen P., Vuolteenaho O., and Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology 132 (1993) 1961-1970
23. Magga J., Vuolteenaho O., Tokola H., Marttila M., and Ruskoaho H. B-type natriuretic peptide: a myocyte-specific marker for characterizing load induced alterations in cardiac gene expression. Ann Med 30 Suppl 1 (1998) 39-45
24. Coodley E.L., Segal J.L., Smith D.H., and Neutel J.M. Bioelectrical impedance analysis as an assessment of diuresis in congestive heart failure. Ann Pharmacother 29 (1995) 1091-1095
25. Troughton R.W., Frampton C.M., Yandle T.G., et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355 (2000) 1126-1130
26. Jourdain P., Gueffet P., Le Helloco A., et al. Benefit of BNP for optimising therapy in patients with heart failure due to systolic dysfunction: The Systolic heart failure treatment supported by BNP trial (STARS-BNP) multicenter randomised study. Eur J Heart Fail Suppl 4 (2005) 120